MECP2, a multi-talented modulator of chromatin architecture
Authors:
- Floriana Della RagioneFRFloriana Della Ragione
- Marcella VaccaMVMarcella Vacca
- Salvatore FiorinielloSalvatore Fioriniello
- Giuseppe PepeGPGiuseppe Pepe
- Maurizio D'ESpositoMDMaurizio D'ESposito
- 12 June 2016
- journal article
- Published by Oxford University Press (OUP) in Briefings in Functional Genomics
- Vol. 15 (6) , elw023-431
Abstract
It has been a long trip from 1992, the year of the discovery of MECP2, to the present day. What is surprising is that some of the pivotal roles of MeCP2 were already postulated at that time, such as repression of inappropriate expression from repetitive elements and the regulation of pericentric heterochromatin condensation. However, MeCP2 performs many more functions. MeCP2 is a reader of epigenetic information contained in methylated (and hydroxymethylated) DNA, moving from the 'classical' CpG doublet to the more complex view addressed by the non-CpG methylation, which is a feature of the postnatal brain. MECP2 is a transcriptional repressor, although when it forms complexes with the appropriate molecules, it can become a transcriptional activator. For all of these aspects, Rett syndrome, which is caused by MECP2 mutations, is considered a paradigmatic example of a ‘chromatin disorder’. Even if the hunt for bona-fide MECP2 target genes is far from concluded today, the role of MeCP2 in the maintenance of chromatin architecture appears to be clearly established. Taking a cue from the non-scientific literature, we can firmly attest that MeCP2 is a player with 'a great future behind it'*.Keywords
This publication has 114 references indexed in Scilit:
- MeCP2 Binds to 5hmC Enriched within Active Genes and Accessible Chromatin in the Nervous SystemCell, 2012
- MeCP2 is required for global heterochromatic and nucleolar changes during activity-dependent neuronal maturationNeurobiology of Disease, 2011
- Rett syndrome: Revised diagnostic criteria and nomenclatureAnnals of Neurology, 2010
- L1 retrotransposition in neurons is modulated by MeCP2Nature, 2010
- The MECP2 duplication syndromeAmerican Journal of Medical Genetics Part A, 2010
- Targeted and genome-scale strategies reveal gene-body methylation signatures in human cellsNature Biotechnology, 2009
- The MBD protein family—Reading an epigenetic mark?Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2008
- Interaction between chromatin proteins MECP2 and ATRX is disrupted by mutations that cause inherited mental retardationProceedings of the National Academy of Sciences, 2007
- Integrative analysis of the cancer transcriptomeNature Genetics, 2005
- Purification, sequence, and cellular localization of a novel chromosomal protein that binds to Methylated DNACell, 1992